Clinical trials
Phase 3 trials in Iran with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shahid Beheshti University of Medical Sciences | 16 |
| Tehran University of Medical Sciences | 10 |
| Royan Institute | 5 |
| Shahid Beheshti University | 4 |
| Shiraz University of Medical Sciences | 4 |
| Isfahan University of Medical Sciences | 3 |
| Mashhad University of Medical Sciences | 3 |
| Rajaie Cardiovascular Medical and Research Center | 2 |
| AryoGen Pharmed Co. | 1 |
| Cinnagen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility | 4 |
| Vitreoretinopathy, Proliferative | 4 |
| Angina, Stable | 2 |
| Cardiovascular Diseases | 2 |
| Coronary Artery Disease | 2 |
| Glaucoma | 2 |
| Inflammation | 2 |
| Macular Degeneration | 2 |
| Osteoarthritis | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.